← All trials
NCT04871282
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 30, 2021
- Primary completion
- Jan 12, 2025
- Completion date
- Feb 21, 2025
- First posted
- May 4, 2021
- Last posted
- Nov 5, 2021
- Enrollment
- 192
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ayala Pharmaceuticals, Inc,Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.